CN112190507A - Composition containing poria cocos extract for removing dark circles and resisting wrinkles as well as preparation method and application of composition - Google Patents
Composition containing poria cocos extract for removing dark circles and resisting wrinkles as well as preparation method and application of composition Download PDFInfo
- Publication number
- CN112190507A CN112190507A CN202011168580.7A CN202011168580A CN112190507A CN 112190507 A CN112190507 A CN 112190507A CN 202011168580 A CN202011168580 A CN 202011168580A CN 112190507 A CN112190507 A CN 112190507A
- Authority
- CN
- China
- Prior art keywords
- wrinkles
- poria cocos
- dark circles
- composition
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000037303 wrinkles Effects 0.000 title claims abstract description 85
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 235000008599 Poria cocos Nutrition 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 241001619444 Wolfiporia cocos Species 0.000 title abstract 4
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims abstract description 27
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims abstract description 27
- 235000001785 ferulic acid Nutrition 0.000 claims abstract description 27
- 229940114124 ferulic acid Drugs 0.000 claims abstract description 27
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims abstract description 27
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229920000669 heparin Polymers 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 19
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 17
- 239000002537 cosmetic Substances 0.000 claims abstract description 17
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 17
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 17
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims abstract description 16
- 229960001008 heparin sodium Drugs 0.000 claims abstract description 16
- 238000003756 stirring Methods 0.000 claims description 34
- 244000197580 Poria cocos Species 0.000 claims description 33
- 238000010438 heat treatment Methods 0.000 claims description 11
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 4
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 150000001851 cinnamic acid derivatives Chemical class 0.000 claims description 2
- 235000002673 Dioscorea communis Nutrition 0.000 abstract description 35
- 241000544230 Dioscorea communis Species 0.000 abstract description 35
- 208000035753 Periorbital contusion Diseases 0.000 abstract description 35
- 230000000694 effects Effects 0.000 abstract description 34
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 9
- 150000004676 glycans Chemical class 0.000 abstract description 8
- 229920001282 polysaccharide Polymers 0.000 abstract description 8
- 239000005017 polysaccharide Substances 0.000 abstract description 8
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 abstract description 5
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 abstract description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract description 5
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 abstract description 5
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 abstract description 5
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 abstract description 5
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 abstract description 5
- 239000000787 lecithin Substances 0.000 abstract description 5
- 235000010445 lecithin Nutrition 0.000 abstract description 5
- 229940067606 lecithin Drugs 0.000 abstract description 5
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 abstract description 5
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 abstract description 5
- 239000000049 pigment Substances 0.000 abstract description 4
- 239000002085 irritant Substances 0.000 abstract description 2
- 231100000021 irritant Toxicity 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 38
- 239000006071 cream Substances 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 8
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 8
- 230000001804 emulsifying effect Effects 0.000 description 8
- 229960002897 heparin Drugs 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000019612 pigmentation Effects 0.000 description 7
- 229940015975 1,2-hexanediol Drugs 0.000 description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 229960001631 carbomer Drugs 0.000 description 6
- 229940100524 ethylhexylglycerin Drugs 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000004475 Arginine Substances 0.000 description 5
- 230000001153 anti-wrinkle effect Effects 0.000 description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 5
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 4
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 230000004855 vascular circulation Effects 0.000 description 4
- 230000008728 vascular permeability Effects 0.000 description 4
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 229940014041 hyaluronate Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 241000282461 Canis lupus Species 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229940100460 peg-100 stearate Drugs 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- -1 polydimethylsiloxane Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 241000530268 Lycaena heteronea Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a composition containing poria cocos extract for removing black eye and resisting wrinkles, and a preparation method and application thereof, wherein the composition containing the poria cocos extract for removing black eye and resisting wrinkles comprises the following components in percentage by weight: 0.0001-10% of poria cocos extract, 0.0001-10% of ferulic acid, 0.0001-10% of acetylated sodium hyaluronate, 0.0001-10% of heparin sodium and the balance of water. Poria contains components such as polysaccharide, pachymic acid, ergosterol, lecithin, etc., and has effect in improving skin sensitivity. Poria extract has anti-inflammatory effect, so as to lighten pigment type black eye. In addition, the composition has the effects of firming skin and helping to reduce wrinkles, and can relieve skin while removing dark circles and wrinkles. The composition for removing black eye circles and resisting wrinkles is mild and non-irritant, can be used as an active component for removing black eye circles and resisting wrinkles, and is applied to eye cosmetics.
Description
Technical Field
The invention relates to the field of cosmetics, and particularly relates to a composition for removing black eye circles and resisting wrinkles and application thereof in removing black eye circles and resisting wrinkles.
Background
The anti-aging is always the focus of long-term attention in the cosmetic industry, along with the rapid improvement of the economic level of China, the requirements of people on anti-aging products are subdivided, in addition, the environmental pollution is serious day by day, the aging of the population is promoted, and the anti-aging cosmetic consumption market is expanded continuously. The skin aging is influenced by the inside and the outside to cause the human body to have a functional or fast or slow natural process, and the eye skin is thin and fragile, so that the aging and sensitive phenomena are more obvious, and the fine wrinkles of the eyes are easily generated. In addition, pigmentation is caused by inflammation due to the weak ultraviolet resistance and sensitivity of the eye skin, and pigmented black eye circles are easily formed. Capillary vessels around eyes are distributed more, and blood circulation is not easy to form blood vessel type black eye circles.
Disclosure of Invention
Aiming at the defects of the prior art, the composition for removing dark circles and resisting wrinkles, disclosed by the invention, has the effect of improving skin sensitivity, and poria cocos contains components such as polysaccharide, pachymic acid, ergosterol, lecithin and the like. The facial pigmentation caused by sensitivity and inflammation around the eyes is easy to form pigmentary black eye circles. Poria extract has anti-inflammatory effect, so as to lighten pigment type black eye. In addition, the composition has the effects of firming skin and helping to reduce wrinkles, and can relieve skin while removing dark circles and wrinkles. Ferulic acid has strong antioxidation and anti-saccharification effects, and acetylated sodium hyaluronate has high water retention effect and strong affinity to skin, so that the composition can remove black eye and wrinkle and can also retain moisture. The heparin sodium can increase the vascular permeability of the skin and improve the local vascular circulation, thereby lightening the vascular black eye. The composition for removing dark circles and resisting wrinkles is mild and non-irritant, can be used as an active component for removing dark circles and resisting wrinkles, and is applied to eye cosmetics.
Specifically, the composition containing the poria extract for removing dark circles and resisting wrinkles comprises the following components in percentage by weight: 0.0001-10% of poria cocos extract, 0.0001-10% of ferulic acid, 0.0001-10% of acetylated sodium hyaluronate, 0.0001-10% of heparin sodium and the balance of water.
In another preferred embodiment, the invention provides a composition containing poria cocos extract for removing dark circles and resisting wrinkles, which comprises the following components in percentage by weight: 0.01-10% of poria cocos extract, 0.01-5% of ferulic acid, 0.01-5% of acetylated sodium hyaluronate, 0.01-5% of heparin sodium and the balance of water.
In another preferred embodiment, the invention provides a composition containing poria cocos extract for removing dark circles and resisting wrinkles, which comprises the following components in percentage by weight: 0.5-10% of poria cocos extract, 0.5-10% of ferulic acid, 0.5-5% of acetylated sodium hyaluronate, 0.5-10% of heparin sodium and the balance of water.
In another preferred embodiment, the invention provides a composition containing poria cocos extract for removing dark circles and resisting wrinkles, which comprises the following components in percentage by weight: 1-10% of poria cocos extract, 1-10% of ferulic acid, 1-10% of acetylated sodium hyaluronate, 1-10% of heparin sodium and the balance of water.
Preferably, the purity of the tuckahoe extract is 80-99.99%.
Preferably, the ferulic acid is one of the derivatives of cinnamic acid, a phenolic acid ubiquitous in plants.
Preferably, the sodium acetylated hyaluronate is a specialty hyaluronic acid derivative.
Preferably, the heparin is a mucopolysaccharide substance.
Preferably, the poria cocos extract has an anti-inflammatory and anti-wrinkle effect, and also has an anti-wrinkle effect, and an effect of improving dark eye circles formed by pigmentation due to inflammation.
Preferably, the ferulic acid has the effects of resisting oxidation and saccharification.
Preferably, the acetylated sodium hyaluronate has high water retention effect.
Preferably, the heparin has the effects of promoting blood circulation and removing dark eye circles.
Preferably, the Poria extract contains polysaccharides, pachymic acid, ergosterol, lecithin, etc., and has effect of improving skin sensitivity. The facial pigmentation caused by sensitivity and inflammation around the eyes is easy to form pigmentary black eye circles. Poria extract has anti-inflammatory effect, so as to lighten pigment type black eye. In addition, it also has effects of tightening skin and reducing wrinkle.
Preferably, the ferulic acid has strong antioxidation, can promote the growth of polysaccharide adherends between cells, plays a role in compacting skin, and is suitable for the use of aging skin.
Preferably, the sodium acetylated hyaluronate has strong affinity to the skin and is firmly retained on the surface of the skin, and provides high water retention capacity.
Preferably, the heparin sodium can increase the vascular permeability of the skin and improve the local vascular circulation, thereby lightening the vascular type black eye.
The invention also provides a black eye circle and wrinkle removing eye cosmetic containing the poria cocos extract, and the black eye circle and wrinkle removing eye cosmetic contains a black eye circle and wrinkle removing composition containing the poria cocos extract.
Preferably, the eye cosmetic for removing black eye circles, removing wrinkles and resisting aging contains 1-15% of the composition for removing black eye circles and resisting wrinkles.
Preferably, the eye cosmetic for removing black eye and resisting wrinkles comprises 10% of the composition for removing black eye and resisting wrinkles.
Preferably, the eye cosmetic for removing black eyes and wrinkles is eye essence for removing black eyes and wrinkles, eye cream for removing black eyes and wrinkles, and eye patch for removing black eyes and wrinkles.
The invention also provides a preparation method of the composition containing the poria cocos extract for removing dark circles and resisting wrinkles, which comprises the following steps:
(1) adding Poria extract into butanediol, heating to above 85 deg.C, and stirring until Poria extract is completely dissolved; after cooling, adding water, ferulic acid, sodium acetylhyaluronate and heparin sodium, and uniformly stirring to obtain the composition containing the poria extract for removing dark circles and resisting wrinkles.
The invention also provides application of the composition containing the poria cocos extract for removing black eyes and resisting wrinkles in preparation of cosmetics containing the poria cocos extract for removing black eyes and resisting wrinkles.
Preferably, the poria cocos extract has an anti-inflammatory and anti-wrinkle effect, and also has an anti-wrinkle effect, and an effect of improving dark eye circles formed by pigmentation due to inflammation.
Preferably, the ferulic acid has an anti-glycation effect.
Preferably, the acetylated sodium hyaluronate has high water retention effect.
Preferably, the heparin has the effects of promoting blood circulation and removing dark eye circles.
Preferably, the Poria extract contains polysaccharide, pachymic acid, ergosterol, lecithin, etc., and has effects of improving skin sensitivity and resisting inflammation, thereby lightening pigmented black eye. In addition, the skin can be firmed, and eye wrinkles can be reduced.
Preferably, the ferulic acid has strong antioxidation and anti-saccharification effects, can promote the growth of polysaccharide adherends between cells, plays a role in compacting skin, and is suitable for the use of aging skin.
Preferably, the sodium acetylated hyaluronate has strong affinity to the skin and is firmly retained on the surface of the skin, and provides high water retention capacity.
Preferably, the heparin sodium can increase the vascular permeability of the skin and improve the local vascular circulation, thereby lightening the vascular type black eye.
Drawings
Fig. 1 shows the results of comparing the fine lines of the eyes of trial No. 1 in example 5.
Fig. 2 shows the results of comparing the fine lines of the eyes of trial 2, example 5.
FIG. 3 shows comparative results of ferulic acid anti-glycation assay.
FIG. 4 shows the anti-inflammatory test results of Poria cocos wolf extract.
Fig. 5 shows the results of comparing the fine lines of the eyes of trial No. 3, example 8.
Fig. 6 shows the results of comparing the fine lines of the eyes of trial No. 4 in example 8.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
Poria contains components such as polysaccharide, pachymic acid, ergosterol, lecithin, etc., and has effect in improving skin sensitivity. The facial pigmentation caused by sensitivity and inflammation around the eyes is easy to form pigmentary black eye circles. Poria extract has anti-inflammatory effect, so as to lighten pigment type black eye. In addition, it also has effects of tightening skin and reducing wrinkle.
Ferulic acid has strong antioxidant effect, can promote the growth of polysaccharide adhesive between cells, has the effect of compacting skin, and is suitable for aging skin. In addition, ferulic acid has the effect of resisting saccharification, and finally inhibits the generation of a glycosylation end product by inhibiting non-enzymatic glycosylation reaction.
Sodium hyaluronate is a distinctive hyaluronic acid-derivative, has a high degree of softness of the stratum corneum, has a strong affinity for the skin, and is firmly retained on the surface of the skin, prevents water from evaporating from the skin, provides a high water retention capacity, and thereby reduces the generation of wrinkles.
The heparin sodium is a mucopolysaccharide substance, can increase the vascular permeability of the skin, improve the local vascular circulation, and has good effect of fading black eye circles and under-eye puffiness. And the heparin can inhibit the loss of mucopolysaccharide of the skin, promote metabolism and inhibit the pigmentation caused by the reduction of the metabolic function.
Example 1
At normal temperature, adding 1% of poria extract dissolved by butanediol, 1% of ferulic acid, 1% of acetylated sodium hyaluronate and 1% of heparin into water, and stirring and dissolving uniformly to obtain the composition for removing black eyes and wrinkle and with the skin-wrinkle-removing effect.
Example 2
Adding 1% of poria extract dissolved by butanediol, 2% of ferulic acid, 2% of acetylated sodium hyaluronate and 2% of heparin into water at normal temperature, and uniformly stirring and dissolving to obtain the composition for removing black eyes and wrinkle and with the skin-wrinkle removing effect.
Example 3
Adding 2% of poria cocos extract dissolved by butanediol, 2% of ferulic acid, 2% of acetylated sodium hyaluronate and 2% of heparin into water at normal temperature, and uniformly stirring and dissolving to obtain the composition for removing black eyes and wrinkle and with the skin-wrinkle removing effect.
Example 4
Adding 3% of poria extract, namely poria extract dissolved by butanediol, 3% of ferulic acid, 3% of acetylated sodium hyaluronate and 1% of heparin into water at normal temperature, and uniformly stirring and dissolving to obtain the composition for removing black eyes and wrinkle and with the skin-wrinkle removing effect.
Example 5 preparation and application of eye essence for removing dark circles and reducing wrinkles
1. Raw materials
Phase A: water (To 100%), carbomer 0.3%, butanediol 3%, disodium EDTA 0.01%;
phase B: 0.3 percent of arginine;
and C phase: the composition for removing dark circles and resisting wrinkles in the embodiment of the invention is 2%;
phase D: 0.5% of 1, 2-hexanediol and 0.4% of phenoxyethanol/ethylhexyl glycerin;
2. preparation process of black eye removing and wrinkle resisting eye essence
(1) Adding phase A into emulsifying pot, homogenizing for 3-5 min, heating to 85 deg.C, and stirring to dissolve completely.
(2) Adding the phase B into the phase A, stirring for 5 minutes, preserving heat for 15 minutes, and defoaming;
(3) cooling to below 45 deg.C, adding C, D phase, stirring, inspecting, and filtering with 150 mesh filter cloth. The black eye removing and wrinkle resisting essence is obtained.
Example 6 preparation and application of eye essence for removing dark circles and reducing wrinkles
1. Raw materials
Phase A: water (To 100%), carbomer 0.3%, butanediol 3%, disodium EDTA 0.01%;
phase B: 0.3 percent of arginine;
and C phase: the composition for removing dark circles and resisting wrinkles in the embodiment of the invention is 2%;
phase D: 0.5% of 1, 2-hexanediol and 0.4% of phenoxyethanol/ethylhexylglycerin
2. Preparation process of black eye removing and wrinkle resisting eye essence
1) Adding phase A into emulsifying pot, homogenizing for 3-5 min, heating to 85 deg.C, and stirring to dissolve completely.
(2) Adding the phase B into the phase A, stirring for 5 minutes, preserving heat for 15 minutes, and defoaming;
(3) cooling to below 45 deg.C, adding C, D phase, stirring, inspecting, and filtering with 150 mesh filter cloth. The black eye removing and wrinkle reducing eye essence is obtained.
Example 7 preparation and application of eye cream for removing dark circles and resisting wrinkles
1. Raw materials
Phase A: water (To 100%), carbomer 0.3%, butanediol 2%, glycerol 6%;
phase B: glyceryl stearate/PEG-100 stearate 1.5%, cetearyl glucoside/cetearyl alcohol 1%, hydrogenated polydecene 2%, isononyl isononanoate 3%, polydimethylsiloxane 1%;
and C phase: 0.3 percent of arginine;
phase D: the composition for removing dark circles and resisting wrinkles in the embodiment of the invention is 2%;
phase E: 0.5% of 1, 2-hexanediol and 0.4% of phenoxyethanol/ethylhexyl glycerin;
2. preparation process of eye cream for removing dark circles and resisting wrinkles
(1) Adding phase A into emulsifying pot, homogenizing for 3-5 min, heating to 85 deg.C, and stirring to dissolve completely.
(2) Adding the phase B into an oil phase pot, stirring and heating to 85 ℃, and stirring until the phase B is completely dissolved;
(3) when the A, B two phases reach the designated temperature, pumping the B phase into the A phase, stirring for 5 minutes, and homogenizing for 3 minutes;
(4) adding the phase C into an emulsifying pot, stirring for 5 minutes, preserving heat for 15 minutes, and defoaming;
(5) cooling to below 45 deg.C, adding D, E phase, stirring, inspecting, and filtering with 150 mesh filter cloth. The eye cream for removing dark circles and resisting wrinkles is obtained.
Example 8 preparation and application of eye cream for removing dark circles and resisting wrinkles
1. Raw materials
Phase A: water (To 100%), carbomer 0.3%, butanediol 2%, glycerol 6%;
phase B: glyceryl stearate/PEG-100 stearate 1.5%, cetearyl glucoside/cetearyl alcohol 1%, hydrogenated polydecene 2%, isononyl isononanoate 3%, polydimethylsiloxane 1%;
and C phase: 0.3 percent of arginine;
phase D: the composition for removing dark circles and resisting wrinkles in the embodiment of the invention is 4%;
phase E: 0.5% of 1, 2-hexanediol and 0.4% of phenoxyethanol/ethylhexyl glycerin;
2. preparation process of eye cream for removing dark circles and resisting wrinkles
(1) Adding phase A into emulsifying pot, homogenizing for 3-5 min, heating to 85 deg.C, and stirring to dissolve completely.
(2) Adding the phase B into an oil phase pot, stirring and heating to 85 ℃, and stirring until the phase B is completely dissolved;
(3) when the A, B two phases reach the designated temperature, pumping the B phase into the A phase, stirring for 5 minutes, and homogenizing for 3 minutes;
(4) adding the phase C into an emulsifying pot, stirring for 5 minutes, preserving heat for 15 minutes, and defoaming;
(5) cooling to below 45 deg.C, adding D, E phase, stirring, inspecting, and filtering with 150 mesh filter cloth. The eye cream for removing dark circles and resisting wrinkles is obtained.
Example 9 preparation and application of eye patch for removing dark circles and resisting wrinkles
1. Raw materials
Phase A: water (To 100%), carbomer 0.15%, glycerin 3%, disodium EDTA 0.01%, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer 0.10%;
phase B: 0.25 percent of arginine;
and C phase: the composition for removing dark circles and resisting wrinkles in the embodiment of the invention is 4%;
phase D: 0.5% of 1, 2-hexanediol and 0.4% of phenoxyethanol/ethylhexyl glycerin;
2. preparation process of black eye removing and wrinkle resisting eye patch
(1) Adding phase A into emulsifying pot, homogenizing for 3-5 min, heating to 85 deg.C, and stirring to dissolve completely.
(2) Adding the phase B into the phase A, stirring for 5 minutes, preserving heat for 15 minutes, and defoaming;
(4) cooling to below 45 deg.C, adding C, D phase, stirring, inspecting, and filtering with 200 mesh filter cloth. The eye patch for removing dark circles and resisting wrinkles is obtained.
Example 10 preparation and application of eye patch for removing dark circles and preventing wrinkles
1. Raw materials
Phase A: water (To 100%), carbomer 0.15%, glycerin 3%, disodium EDTA 0.01%, acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer 0.10%;
phase B: 0.25 percent of triethanolamine;
and C phase: the composition for removing dark circles and resisting wrinkles in the embodiment of the invention is 2%;
phase D: 0.5% of 1, 2-hexanediol and 0.4% of phenoxyethanol/ethylhexyl glycerin;
2. preparation process of black eye removing and wrinkle resisting eye patch
(1) Adding phase A into emulsifying pot, homogenizing for 3-5 min, heating to 85 deg.C, and stirring to dissolve completely.
(2) Adding the phase B into the phase A, stirring for 5 minutes, preserving heat for 15 minutes, and defoaming;
(4) cooling to below 45 deg.C, adding C, D phase, stirring, inspecting, and filtering with 200 mesh filter cloth. The eye patch for removing dark circles and resisting wrinkles is obtained.
In order to better illustrate the advantages of the invention, aiming at the eye product of tuckahoe extract for removing dark circles and wrinkles, the safety and efficacy of the composition obtained by the invention are tested and analyzed by adopting a special cosmetic efficacy evaluation method, and the detection results are as follows:
1. evaluation of anti-wrinkle Effect of sodium acetylhyaluronate
The experimental method comprises the following steps:
firstly, randomly extracting 20 testers, cleaning the face before testing, resting for 15 minutes at a fixed position, testing the periocular region by using a skin tester VISIA machine, and recording the condition.
② the eye essence for removing dark circles, wrinkles and aging of the eye part of the embodiment 5 is smeared, the eye part is massaged until the essence is completely absorbed, after one month of use, the eye part is tested by a VISIA machine of a skin tester, and the condition is recorded.
The results are shown in fig. 1 and 2, and the fine lines of the eyes after one month trial of the eye cream of example 5 are clearly lighter than before use. Proves that the acetylated sodium hyaluronate has the effect of resisting wrinkles.
3. The experimental method for evaluating the anti-saccharification effect of the ferulic acid comprises the following steps:
(1) the sugar and protein may undergo a glycation reaction which may yellow the protein. Setting experimental group samples, stirring uniformly by using 30g of egg white and 20g of deionized water, adding 0.2% of ferulic acid, stirring again, finally adding 0.5g of sugar, and stirring uniformly. A blank set of samples was set and stirred well with 30g egg white and 20g deionized water. A control sample is set, 30g of egg white and 20g of deionized water are uniformly stirred, 0.5g of sugar is added, and then the mixture is uniformly stirred. And (3) putting the prepared three groups of samples into a water bath kettle, setting the temperature to be 90 ℃, and heating for two hours.
The results are shown in fig. 3, the comparison between the anti-sugar effect of the experimental group added with ferulic acid and the control group is obvious, and the ferulic acid is proved to have the anti-saccharification effect and can slow down the saccharification process of the skin.
4. Evaluation of anti-inflammatory Effect of Poria extract
(1) Histamine is irritating and when applied to the skin, it can cause redness in addition to itching. The same size area of the arm of the subject is painted with 3% histamine solution, the prepared sample solution is respectively painted on the corresponding area, and the skin of the subject is observed after 15min and 30 min.
As shown in FIG. 4, the comparison of the areas of the control group and the blank group to which the subjects applied proves that the Poria cocos wolf extract has a very good anti-inflammatory effect, is superior to the blue copper peptide solution in effect, and can alleviate the damage to the eye skin due to external stimulation.
5. Evaluation of black eye removing effect of heparin sodium
The experimental method comprises the following steps:
firstly, randomly extracting 20 testers, cleaning the face before testing, resting for 15 minutes at a fixed position, testing the periocular region by using a skin tester VISIA machine, and recording the condition.
② smearing the eye cream for removing dark circles and resisting wrinkles of the embodiment 8, massaging until the eye cream is completely absorbed, using the eye cream for one month, testing the area around the eyes by a skin tester VISIA machine, and recording the condition.
The results are shown in fig. 5 and 6, and the dark circles after one month trial of the eye cream of example 8 are clearly lighter than before use. The heparin sodium is proved to have the effect of removing dark eye circles.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (10)
1. A composition containing poria cocos extract for removing dark circles and resisting wrinkles is characterized by comprising the following components in percentage by weight: 0.0001-10% of poria cocos extract, 0.0001-10% of ferulic acid, 0.0001-10% of acetylated sodium hyaluronate, 0.0001-10% of heparin sodium and the balance of water.
2. A composition containing poria cocos extract for removing dark circles and resisting wrinkles is characterized by comprising the following components in percentage by weight: 0.0001-10% of poria cocos extract, 0.0001-10% of ferulic acid, 0.0001-10% of acetylated sodium hyaluronate, 0.0001-10% of heparin sodium and the balance of water.
3. The composition containing the poria cocos extract for removing dark circles and resisting wrinkles as claimed in claim 1, wherein the purity of the poria cocos extract is 80-99.99%.
4. The composition containing Poria cocos extract for removing dark circles and removing wrinkles as claimed in claim 1, wherein the ferulic acid is one of cinnamic acid derivatives.
5. The composition for removing dark circles and resisting wrinkles, as claimed in claim 1, wherein the acetylated sodium hyaluronate is a characteristic hyaluronic acid derivative.
6. The composition of claim 1, wherein the heparin sodium is a mucopolysaccharide.
7. An eye cosmetic containing a poria cocos extract for removing black eyes and resisting wrinkles, which is characterized by comprising the poria cocos extract-containing eye cosmetic composition according to any one of claims 1 to 6.
8. The poria cocos extract-containing eye cosmetic for removing and preventing wrinkles in dark circles according to claim 7, wherein the eye cosmetic for removing and preventing wrinkles in dark circles comprises 0.0001-10% of the composition for removing and preventing wrinkles in dark circles.
9. The method for preparing the composition containing the tuckahoe extract for removing dark circles and resisting wrinkles as claimed in claim 1 is characterized by comprising the following steps:
(1) preparing raw materials according to the proportion of the components;
(2) adding Poria extract into butanediol, heating to 85 deg.C, and cooling after completely dissolving; after cooling, adding water, ferulic acid, sodium acetylhyaluronate and heparin sodium, and uniformly stirring to obtain the composition containing the poria extract for removing dark circles and resisting wrinkles.
10. Use of the poria cocos extract-containing composition for removing dark circles and wrinkles as claimed in any one of claims 1 to 7 in preparation of a cosmetic for removing dark circles and wrinkles for eyes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011168580.7A CN112190507A (en) | 2020-10-28 | 2020-10-28 | Composition containing poria cocos extract for removing dark circles and resisting wrinkles as well as preparation method and application of composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011168580.7A CN112190507A (en) | 2020-10-28 | 2020-10-28 | Composition containing poria cocos extract for removing dark circles and resisting wrinkles as well as preparation method and application of composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112190507A true CN112190507A (en) | 2021-01-08 |
Family
ID=74011640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011168580.7A Pending CN112190507A (en) | 2020-10-28 | 2020-10-28 | Composition containing poria cocos extract for removing dark circles and resisting wrinkles as well as preparation method and application of composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112190507A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113876656A (en) * | 2021-10-29 | 2022-01-04 | 湖北省麦诗特生物科技有限公司 | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof |
| CN114028291A (en) * | 2021-11-30 | 2022-02-11 | 广州环亚化妆品科技股份有限公司 | Composition for improving dark eye circles and preparation method and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005263652A (en) * | 2004-03-17 | 2005-09-29 | Kao Corp | Skin symptom-improving agent |
| CN102188360A (en) * | 2011-04-27 | 2011-09-21 | 重庆时珍阁普生药业有限公司 | Application of leech to improvement of black eyes or eye puffiness, composition and preparation method of composition |
| CN104208107A (en) * | 2014-08-14 | 2014-12-17 | 广东省食品工业研究所 | Poria cocos extract, and preparation method and application thereof |
| CN105963235A (en) * | 2016-06-28 | 2016-09-28 | 龙梅奎 | Dark circle removal eye mask |
| CN109998949A (en) * | 2018-01-04 | 2019-07-12 | 广州佳洁化妆品有限公司 | A kind of heparin sodium, rutin, the eye cream of coffee-extract development and preparation method |
| CN111743797A (en) * | 2020-07-01 | 2020-10-09 | 广州市爱百伊生物技术有限公司 | Moisturizing and repairing composition with instant long-acting wrinkle-removing effect and application thereof |
-
2020
- 2020-10-28 CN CN202011168580.7A patent/CN112190507A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005263652A (en) * | 2004-03-17 | 2005-09-29 | Kao Corp | Skin symptom-improving agent |
| CN102188360A (en) * | 2011-04-27 | 2011-09-21 | 重庆时珍阁普生药业有限公司 | Application of leech to improvement of black eyes or eye puffiness, composition and preparation method of composition |
| CN104208107A (en) * | 2014-08-14 | 2014-12-17 | 广东省食品工业研究所 | Poria cocos extract, and preparation method and application thereof |
| CN105963235A (en) * | 2016-06-28 | 2016-09-28 | 龙梅奎 | Dark circle removal eye mask |
| CN109998949A (en) * | 2018-01-04 | 2019-07-12 | 广州佳洁化妆品有限公司 | A kind of heparin sodium, rutin, the eye cream of coffee-extract development and preparation method |
| CN111743797A (en) * | 2020-07-01 | 2020-10-09 | 广州市爱百伊生物技术有限公司 | Moisturizing and repairing composition with instant long-acting wrinkle-removing effect and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 湖南卫视我是大美人: "熬夜少女救星！用了它，黑眼圈、眼纹、眼袋都没了！_眼霜", 《HTTPS://WWW.SOHU.COM/A/259129216_311118》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113876656A (en) * | 2021-10-29 | 2022-01-04 | 湖北省麦诗特生物科技有限公司 | Black eye and pouch removing soluble beautifying microneedle patch composition and preparation method thereof |
| CN114028291A (en) * | 2021-11-30 | 2022-02-11 | 广州环亚化妆品科技股份有限公司 | Composition for improving dark eye circles and preparation method and application thereof |
| CN114028291B (en) * | 2021-11-30 | 2023-02-03 | 广州环亚化妆品科技股份有限公司 | Composition for improving dark eye circles and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105997754B (en) | A kind of camellia extract solution and preparation method and application | |
| CN108324606B (en) | Pitaya stem extract and preparation method and application thereof | |
| CN103070810B (en) | Anti-skin-aging composition | |
| CN104940049B (en) | Extracting method, extract and the application of yacon plant extracts | |
| CN110585048B (en) | Composition with anti-saccharification and anti-oxidation functions and application thereof | |
| CN110090167B (en) | Biological polysaccharide for ultraviolet injury repair and application thereof | |
| CN112190507A (en) | Composition containing poria cocos extract for removing dark circles and resisting wrinkles as well as preparation method and application of composition | |
| CN111544372A (en) | Fermentation product compound plant extract anti-aging repair composition, application and essence milk containing composition | |
| CN114224768B (en) | Repairing and anti-aging composition and preparation method thereof | |
| CN112472631B (en) | Multi-effect eye essence and preparation method thereof | |
| CN109223677B (en) | Coix seed hydrolysate, preparation method thereof and application of coix seed hydrolysate in cosmetics | |
| CN112641702A (en) | Wrinkle-removing and anti-aging composition and preparation method and application thereof | |
| CN111529427A (en) | Active polypeptide compound plant extract anti-aging repair composition, application and essence milk containing composition | |
| CN111603434A (en) | Composition for improving skin wrinkles and cosmetic thereof | |
| KR102065607B1 (en) | cosmetic composition for skin moisturizing and skin elasticity using palm oil fraction | |
| CN111728886A (en) | Whitening composition and preparation method and application thereof | |
| CN114272172B (en) | Whitening and soothing composition and preparation method thereof | |
| CN117045564B (en) | Skin care product containing peony extract and preparation method thereof | |
| CN109394640B (en) | Enzyme skin care composition and application thereof | |
| CN107468568A (en) | A kind of persimmon leaf polyphenol with whitening sun protection activity and its preparation method and application | |
| CN114642614A (en) | Composition containing ganoderma lucidum and poria cocos and application thereof | |
| CN111658587B (en) | Collagenase inhibitor composition, anti-aging water dew and preparation method thereof | |
| CN111388394A (en) | Biphase freeze-dried powder solvent and preparation method and application thereof | |
| CN115607487B (en) | Skin brightening and anti-aging preparation and application thereof | |
| CN110227050A (en) | A kind of anti-aging maintenance sustained release Essence and the anti-aging Face-protecting mask using its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210108 |